SEC Filings

10-K
AVEXIS, INC. filed this Form 10-K on 02/28/2018
Entire Document
 

PART II

Item 5.  Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Market Information for Common Stock

Our common stock commenced trading on The Nasdaq Global Select Market under the symbol “AVXS” on February 12, 2016. Prior to our initial public offering, there was no public market for our common stock. The following table sets forth the high and low daily sale prices for our common stock for each calendar quarter during 2017 and 2016, as reported on the Nasdaq Global Select Market:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2017

 

2016 (a)

 

    

High

    

Low

 

High

 

Low

First Quarter

 

$

85.98

 

$

46.41

 

$

29.63

 

$

16.11

Second Quarter

 

 

83.59

 

 

65.23

 

 

47.76

 

 

20.51

Third Quarter

 

 

101.67

 

 

76.38

 

 

46.02

 

 

31.55

Fourth Quarter

 

 

116.15

 

 

90.73

 

 

72.72

 

 

40.56

(a)

First quarter 2016 data is from February 12, 2016, the first day that AVXS began trading on The Nasdaq Global Select Market.

 

On February 26, 2018, the closing price for our common stock as reported on The Nasdaq Global Select Market was $123.77 per share.

Performance Graph

The graph below compares the 23‑month cumulative total stockholder return on our common stock, the Nasdaq Stock Market (US) Index, and the Nasdaq Composite Index and the Nasdaq Biotechnology Index, assuming the investment of $100.00 on February 12, 2016, the first day that AVXS began trading on The Nasdaq Global Select Market upon our initial public offering, with dividends being reinvested. The historical stock price performance in the graph below is not necessarily indicative of future price performance.

Picture 6

93


 


© AveXis, Inc. All Rights Reserved.